Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Huya Bioscience International
AddedFeb 15, 2024
UpdatedJun 18, 2026
Huya Bioscience International

Huya Bioscience International

San Diego-based HUYA Bioscience International LLC advances pharmaceutical research and global marketing of early-stage compounds.

HQ
San Diego, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Founded in San Diego, California, HUYA Bioscience International LLC focuses on advancing pharmaceutical research and the global marketing of early-stage compounds. The company's core mission is to meet unmet medical needs by accelerating the global development of novel biopharmaceutical products originating in China. HUYA leverages strategic partnerships to position promising compounds for development in international markets, offering a unique advantage through its world-class commercial scientific expertise.

Notable figures affiliated with HUYA include President & CEO Dr. Mireille Gillings. The company has achieved significant milestones in globalizing China's biopharma innovation, enabling faster, more cost-effective, and lower-risk drug development. HUYA's impact is evident in its ability to bridge the gap between Chinese biopharma innovations and global markets, thereby enhancing the availability of cutting-edge medical treatments worldwide.

Huya Bioscience International - Similar Companies

Sinogen Biopharma logo

Sinogen Biopharma

Brii Biosciences logo

Brii Biosciences

briibio.com

China PharmaHub logo

China PharmaHub

Shanghai Junshi Biosciences Co logo

Shanghai Junshi Biosciences Co

junshipharma.com

Kyntra Bio logo

Kyntra Bio

fibrogen.com

Hengrui Therapeutics logo

Hengrui Therapeutics

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

BioQ Pharma logo

BioQ Pharma

bioqpharma.com

HI-Bio logo

HI-Bio

hibio.com

ISI Life Sciences logo

ISI Life Sciences

Sinopia Biosciences logo

Sinopia Biosciences

sinopiabio.com

BiotechInnova logo

BiotechInnova

biotechinnova.com

WuXi Biologics logo

WuXi Biologics

wuxibiologics.com

Harmony Biosciences logo

Harmony Biosciences

Hapten Sciences logo

Hapten Sciences

haptensciences.com

Huya Bioscience International - Quick Facts

Who are Huya Bioscience International's competitors?

Companies similar to Huya Bioscience International include Sinogen Biopharma, Brii Biosciences, China PharmaHub and Shanghai Junshi Biosciences Co.

When was Huya Bioscience International founded?

Huya Bioscience International was founded in 2004.

Where is Huya Bioscience International's headquarters located?

Huya Bioscience International's headquarters is located in San Diego, CA, US.

When was Huya Bioscience International's last funding round?

Huya Bioscience International's most recent funding round was for $48M (USD) in April 2015.

How much has Huya Bioscience International raised to-date?

As of Apr 22, 2015, Huya Bioscience International has raised a total of $60.6M (USD).

How many employees does Huya Bioscience International have?

Huya Bioscience International has 119 employees as of Feb 5, 2024.

Huya Bioscience International - Classification

Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Drug Development
  • Pharmaceuticals
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified